Genetic Vaccination for the Immunotherapy of B-Cell Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|2|2|235-242

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.2, Iss.2, 2002-01, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem Cell Transplant and Idiotypic Vaccination for B-Cell Malignancies

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 13, 2011-07 ,pp. : 1653-1660

Bentham Science Publishers

Access to resources Recommend Favorite

Current status of Immunotherapy in B Cell Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1371-1374

Bentham Science Publishers

Access to resources Recommend Favorite

Idiotype Vaccines for Human B-Cell Malignancies

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 300-307

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Vaccination for the Active Immunotherapy of Cancer

By  

Current Gene Therapy, Vol. 1, Iss. 1, 2001-05 ,pp. : 53-100

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

By Korycka-Wołowiec Anna   Robak Tadeusz  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1455-1468

Informa Healthcare

Access to resources Recommend Favorite